811 related articles for article (PubMed ID: 21302010)
1. Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models.
Bergstrand M; Hooker AC; Wallin JE; Karlsson MO
AAPS J; 2011 Jun; 13(2):143-51. PubMed ID: 21302010
[TBL] [Abstract][Full Text] [Related]
2. Standardized visual predictive check versus visual predictive check for model evaluation.
Wang DD; Zhang S
J Clin Pharmacol; 2012 Jan; 52(1):39-54. PubMed ID: 21257797
[TBL] [Abstract][Full Text] [Related]
3. A Regression Approach to Visual Predictive Checks for Population Pharmacometric Models.
Jamsen KM; Patel K; Nieforth K; Kirkpatrick CMJ
CPT Pharmacometrics Syst Pharmacol; 2018 Oct; 7(10):678-686. PubMed ID: 30058222
[TBL] [Abstract][Full Text] [Related]
4. [Comparison study of model evaluation methods: normalized prediction distribution errors vs. visual predictive check].
Ren YP; Deng CH; Wang XP; Zhou TY; Lu W
Yao Xue Xue Bao; 2011 Sep; 46(9):1123-31. PubMed ID: 22121786
[TBL] [Abstract][Full Text] [Related]
5. Visual Predictive Check in Models with Time-Varying Input Function.
Largajolli A; Bertoldo A; Campioni M; Cobelli C
AAPS J; 2015 Nov; 17(6):1455-63. PubMed ID: 26265094
[TBL] [Abstract][Full Text] [Related]
6. Development of visual predictive checks accounting for multimodal parameter distributions in mixture models.
Arshad U; Chasseloup E; Nordgren R; Karlsson MO
J Pharmacokinet Pharmacodyn; 2019 Jun; 46(3):241-250. PubMed ID: 30968312
[TBL] [Abstract][Full Text] [Related]
7. Extensions to the visual predictive check to facilitate model performance evaluation.
Post TM; Freijer JI; Ploeger BA; Danhof M
J Pharmacokinet Pharmacodyn; 2008 Apr; 35(2):185-202. PubMed ID: 18197467
[TBL] [Abstract][Full Text] [Related]
8. PFIM 4.0, an extended R program for design evaluation and optimization in nonlinear mixed-effect models.
Dumont C; Lestini G; Le Nagard H; Mentré F; Comets E; Nguyen TT;
Comput Methods Programs Biomed; 2018 Mar; 156():217-229. PubMed ID: 29428073
[TBL] [Abstract][Full Text] [Related]
9. Exploratory population pharmacokinetics (e-PPK) analysis for predicting human PK using exploratory ADME data during early drug discovery research.
Tabata K; Hamakawa N; Sanoh S; Terashita S; Teramura T
Eur J Drug Metab Pharmacokinet; 2009; 34(2):117-28. PubMed ID: 19645221
[TBL] [Abstract][Full Text] [Related]
10. Inverse probability of censoring weighting for visual predictive checks of time-to-event models with time-varying covariates.
Bartels C; Dumortier T
Pharm Stat; 2021 Nov; 20(6):1051-1060. PubMed ID: 33855777
[TBL] [Abstract][Full Text] [Related]
11. Automatic data binning for improved visual diagnosis of pharmacometric models.
Lavielle M; Bleakley K
J Pharmacokinet Pharmacodyn; 2011 Dec; 38(6):861-71. PubMed ID: 22042498
[TBL] [Abstract][Full Text] [Related]
12. Influence of covariance between random effects in design for nonlinear mixed-effect models with an illustration in pediatric pharmacokinetics.
Dumont C; Chenel M; Mentré F
J Biopharm Stat; 2014; 24(3):471-92. PubMed ID: 24697342
[TBL] [Abstract][Full Text] [Related]
13. Model-Based Residual Post-Processing for Residual Model Identification.
Ibrahim MMA; Nordgren R; Kjellsson MC; Karlsson MO
AAPS J; 2018 Jul; 20(5):81. PubMed ID: 29968184
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetic and pharmacodynamic analyses of safinamide in subjects with Parkinson's disease.
Loprete L; Leuratti C; Cattaneo C; Thapar MM; Farrell C; Sardina M
Pharmacol Res Perspect; 2016 Oct; 4(5):e00251. PubMed ID: 27713822
[TBL] [Abstract][Full Text] [Related]
15. Conditional weighted residuals (CWRES): a model diagnostic for the FOCE method.
Hooker AC; Staatz CE; Karlsson MO
Pharm Res; 2007 Dec; 24(12):2187-97. PubMed ID: 17612795
[TBL] [Abstract][Full Text] [Related]
16. A general method to determine sampling windows for nonlinear mixed effects models with an application to population pharmacokinetic studies.
Foo LK; McGree J; Duffull S
Pharm Stat; 2012; 11(4):325-33. PubMed ID: 22411749
[TBL] [Abstract][Full Text] [Related]
17. The first study in pediatric: Population pharmacokinetics of sirolimus and its application in Chinese children with immune cytopenia.
Cheng X; Zhao Y; Gu H; Zhao L; Zang Y; Wang X; Wu R
Int J Immunopathol Pharmacol; 2020; 34():2058738420934936. PubMed ID: 32720540
[TBL] [Abstract][Full Text] [Related]
18. IMI - Oral biopharmaceutics tools project - Evaluation of bottom-up PBPK prediction success part 4: Prediction accuracy and software comparisons with improved data and modelling strategies.
Ahmad A; Pepin X; Aarons L; Wang Y; Darwich AS; Wood JM; Tannergren C; Karlsson E; Patterson C; Thörn H; Ruston L; Mattinson A; Carlert S; Berg S; Murphy D; Engman H; Laru J; Barker R; Flanagan T; Abrahamsson B; Budhdeo S; Franek F; Moir A; Hanisch G; Pathak SM; Turner D; Jamei M; Brown J; Good D; Vaidhyanathan S; Jackson C; Nicolas O; Beilles S; Nguefack JF; Louit G; Henrion L; Ollier C; Boulu L; Xu C; Heimbach T; Ren X; Lin W; Nguyen-Trung AT; Zhang J; He H; Wu F; Bolger MB; Mullin JM; van Osdol B; Szeto K; Korjamo T; Pappinen S; Tuunainen J; Zhu W; Xia B; Daublain P; Wong S; Varma MVS; Modi S; Schäfer KJ; Schmid K; Lloyd R; Patel A; Tistaert C; Bevernage J; Nguyen MA; Lindley D; Carr R; Rostami-Hodjegan A
Eur J Pharm Biopharm; 2020 Nov; 156():50-63. PubMed ID: 32805361
[TBL] [Abstract][Full Text] [Related]
19. Pharmacometrics: modelling and simulation tools to improve decision making in clinical drug development.
Gieschke R; Steimer JL
Eur J Drug Metab Pharmacokinet; 2000; 25(1):49-58. PubMed ID: 11032091
[TBL] [Abstract][Full Text] [Related]
20. Nonlinear mixed-effects models with misspecified random-effects distribution.
Drikvandi R
Pharm Stat; 2020 May; 19(3):187-201. PubMed ID: 31663263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
